Results 231 to 240 of about 10,538,494 (333)

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

Obesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone, Mary Playdon, Stephen D. Hursting, Aik Choon Tan   +3 more
wiley   +1 more source

A Case Study and Review of the Literature on IgA Nephropathy in Crohn's Disease. [PDF]

Clin Case Rep
Vazzana GF, Romano A, Casuscelli C, La Spada A, Santoro D, Chimenz R, Romano C.   +6 more
europepmc   +1 more source

Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency

Obesity, EarlyView.
ABSTRACT Setmelanotide, a melanocortin 4 receptor (MC4R) agonist, is a promising pharmacological treatment option for people with rare monogenic obesity conditions affecting the leptin‐melanocortin signaling pathway, including proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations.
Ellina Lytvyak, Arshdeep Rattol, Eduardo Grunvald   +2 more
wiley   +1 more source

Upadacitinib for the Treatment of Cutaneous Crohn's Disease Presenting as Lymphangioma Circumscriptum. [PDF]

ACG Case Rep J
Gerstein B, Lau WC, Bitterman A, Adalsteinsson JA, Gottlieb Z, Kassenoff R, Cices A.   +6 more
europepmc   +1 more source

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.

Journal of Crohn's & Colitis, 2014
F. Ruemmele, G. Veres, K. Kolho, A. Griffiths, A. Levine, J. Escher, J. A. Dias, A. Barabino, C. Braegger, J. Bronský, S. Buderus, J. Martín-de-Carpi, L. Ridder, U. Fagerberg, J. Hugot, J. Kierkuś, S. Kolaček, Sibylle Koletzko, P. Lionetti, E. Miele, V. N. Lopez, A. Paerregaard, R. Russell, D. Serban, R. Shaoul, P. Rheenen, G. Veereman, B. Weiss, D. Wilson, A. Dignass, A. Eliakim, H. Winter, D. Turner   +32 more
semanticscholar   +1 more source

Redefining “Comorbidity” in Dermatology: Beyond Terminology, Lessons From Other Specialties

JEADV Clinical Practice, EarlyView.
Patricia Garbayo‐Salmons, Mireia Moreno   +1 more
wiley   +1 more source

ChatGPT-Assisted Image Interpretation for Inflammatory Bowel Diseases: Ulcerative Colitis and Crohn's Disease. [PDF]

JGH Open
Uekado H, Watanabe D, Aoyama Y, Kawase H, Ikeda S, Shiraki A, Pajimna J, Agawa M, Nakamura H, Ito Y, Okamoto N, Miyazaki H, Ku Y, Ooi M, Hoshi N, Kodama Y.   +15 more
europepmc   +1 more source

The N‐Glycome to Differentiate Mesenchymal Stem Cells Upon Chondrogenic Differentiation, Dedifferentiation, and Senescence

PROTEOMICS, EarlyView.
ABSTRACT Mesenchymal stem cells (MSCs) are adult stem cells able to self‐renewal or differentiation into different cell types, including chondrocytes. N‐Glycans are post‐translational modifications of glycoproteins that contribute to vital cell functions.
Houda Montacir, Karina Biskup, Michael Sittinger, Rudolf Tauber, Véronique Blanchard   +4 more
wiley   +1 more source

Organ Preservation After Total Neoadjuvant Therapy in a Patient With Low Rectal Adenocarcinoma and Crohn's Disease. [PDF]

ACG Case Rep J
Leong R, Goodwin R, Moloo H, Shabana W, Locke G.   +4 more
europepmc   +1 more source

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.

Journal of Crohn's & Colitis, 2006
G. Van Assche, A. Dignass, J. Panés, L. Beaugerie, J. Karagiannis, M. Allez, T. Ochsenkühn, T. Orchard, G. Rogler, E. Louis, L. Kupčinskas, G. Mantzaris, S. Travis, E. Stange   +13 more
semanticscholar   +1 more source